Liver transplant success rate
Reading File
Searching the Web
liver transplant success rate survival statistics 2024 2025
Searching PubMed
"liver transplantation"[MeSH Terms] AND "survival rate"[MeSH Terms]
Finding Sources
Reading File
Reading File
Reading File
Here is a thorough breakdown of liver transplant success rates, drawing from surgical textbooks, recent registry data, and current literature:
Liver Transplant Success Rates
Overall Survival Rates (Adults)
| Timepoint | Survival Rate |
|---|---|
| 1-year | ~85-90% |
| 5-year | ~74-75% |
| 10-year | ~55-60% |
These figures come from large registry data. The American Liver Foundation cites an 89% 1-year survival and 75% 5-year survival based on recent registry reports. In 2024, 11,458 liver transplants were performed in the US (10,854 from deceased donors, 604 from living donors).
Survival by Underlying Disease (5-year OS)
| Indication | 5-Year Survival |
|---|---|
| Primary sclerosing cholangitis (PSC) | ~85-86% |
| Hepatitis B (HBV) | ~83% |
| Hepatitis C (HCV) | ~74-75% |
| Alcoholic cirrhosis | ~70-75% |
| HCC (within Milan criteria) | ~73% |
| HCC (outside Milan criteria) | ~53% |
| Metabolic dysfunction-associated steatohepatitis (MASH) | Comparable to other cirrhosis indications |
For PSC specifically, textbook data reports 5-year actuarial survival and graft function of 85% and 72% respectively (Maingot's Abdominal Operations). A 2024 meta-analysis in Hepatology (Ciria et al.) showed 5-year OS rates for transplant oncology indications (e.g., neuroendocrine tumors: 63.2%; perihilar cholangiocarcinoma: 72.5%; colorectal liver metastases: 50.9%) remain above the minimum 50% benchmark when strict selection criteria are applied.
Pediatric Outcomes
Pediatric liver transplants have some of the best outcomes of any transplant type:
- 1-year survival rate: ~90%
- Most common indication: biliary atresia
- (Schwartz's Principles of Surgery, 11th ed.)
Historical Context
Early liver transplant survival (1967-late 1970s) was dismal - only 20% of recipients survived beyond 5 years. The introduction of cyclosporine (1978) and later tacrolimus (1990s) dramatically improved outcomes. Today's ~90% 1-year survival reflects decades of improvements in immunosuppression, cold organ preservation, and surgical technique - (Schwartz's Principles of Surgery, 11th ed.)
Key Factors Affecting Success
Factors that improve outcomes:
- Living donor transplants (slightly better graft quality)
- Lower MELD score at transplant (though a minimum MELD of 18 is needed to show a survival benefit over remaining on the waitlist)
- Younger recipient age
- High-volume transplant centers
Factors that worsen outcomes:
- Sarcopenia (muscle wasting) - a 2025 meta-analysis (PMID 39876624) confirmed sarcopenia is a significant predictor of post-transplant mortality in cirrhosis
- MELD score ≥ 30 at the time of transplant
- Obesity (Class III+)
- Donor risk index (older, marginal donors)
- Disease recurrence (HCV historically; now largely eliminated with direct-acting antivirals)
Graft Survival vs. Patient Survival
These are distinct metrics:
- Patient survival - whether the recipient is alive
- Graft survival - whether the transplanted liver is still functioning
Graft survival is slightly lower than patient survival at each time point, because some patients survive after re-transplantation if the first graft fails.
Long-term Perspective
Recipients have been documented to live normal lives for 30+ years after transplantation. The transplanted liver does not age at the same rate as the rest of the body, and many long-term complications relate to chronic immunosuppression (infection, malignancy, metabolic syndrome) rather than graft failure itself.
This is a shared conversation. Sign in to Orris to start your own chat.